# Study of the Value of Trio Exome Sequencing in the Etiological Assessment of Specific Non-syndromic Language and Learning Disorders

> **NCT05939739** · NA · RECRUITING · sponsor: **Centre Hospitalier Universitaire Dijon** · enrollment: 101 (estimated)

## Conditions studied

- Specific Language and Learning Disorders (SLLD)

## Interventions

- **BIOLOGICAL:** Blood samples
- **OTHER:** Consultation for results delivery
- **OTHER:** Study Humanities and Social Sciences

## Key facts

- **NCT ID:** NCT05939739
- **Lead sponsor:** Centre Hospitalier Universitaire Dijon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-07
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 101 (ESTIMATED)
- **Last updated:** 2025-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05939739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05939739, "Study of the Value of Trio Exome Sequencing in the Etiological Assessment of Specific Non-syndromic Language and Learning Disorders". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05939739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*